MiMedx Stock Forecast - Skewness

MDXG Stock  USD 9.22  0.16  1.77%   
MiMedx Stock Forecast is based on your current time horizon. We recommend always using this module together with an analysis of MiMedx's historical fundamentals, such as revenue growth or operating cash flow patterns.
  
At this time, MiMedx's Inventory Turnover is most likely to slightly decrease in the upcoming years. The MiMedx's current Fixed Asset Turnover is estimated to increase to 37.07, while Payables Turnover is projected to decrease to 3.26. . The current Common Stock Shares Outstanding is estimated to decrease to about 94.7 M. The MiMedx's current Net Loss is estimated to increase to about (31.4 M).
MiMedx Group has current Skewness of 0.
Check MiMedx VolatilityBacktest MiMedxInformation Ratio  

MiMedx Trading Date Momentum

On November 21 2024 MiMedx Group was traded for  9.22  at the closing time. The top price for the day was 9.34  and the lowest listed price was  9.06 . The trading volume for the day was 699.6 K. The trading history from November 21, 2024 did not cause price change. The trading delta at closing time against the current closing price is 1.74% .
Compare MiMedx to competition

Other Forecasting Options for MiMedx

For every potential investor in MiMedx, whether a beginner or expert, MiMedx's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. MiMedx Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in MiMedx. Basic forecasting techniques help filter out the noise by identifying MiMedx's price trends.

View MiMedx Related Equities

 Risk & Return  Correlation

MiMedx Group Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of MiMedx's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of MiMedx's current price.

MiMedx Market Strength Events

Market strength indicators help investors to evaluate how MiMedx stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading MiMedx shares will generate the highest return on investment. By undertsting and applying MiMedx stock market strength indicators, traders can identify MiMedx Group entry and exit signals to maximize returns.

MiMedx Risk Indicators

The analysis of MiMedx's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in MiMedx's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting mimedx stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Currently Active Assets on Macroaxis

When determining whether MiMedx Group is a strong investment it is important to analyze MiMedx's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact MiMedx's future performance. For an informed investment choice regarding MiMedx Stock, refer to the following important reports:
Check out Historical Fundamental Analysis of MiMedx to cross-verify your projections.
You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MiMedx. If investors know MiMedx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MiMedx listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.1)
Earnings Share
0.57
Revenue Per Share
2.447
Quarterly Revenue Growth
0.029
Return On Assets
0.1838
The market value of MiMedx Group is measured differently than its book value, which is the value of MiMedx that is recorded on the company's balance sheet. Investors also form their own opinion of MiMedx's value that differs from its market value or its book value, called intrinsic value, which is MiMedx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MiMedx's market value can be influenced by many factors that don't directly affect MiMedx's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MiMedx's value and its price as these two are different measures arrived at by different means. Investors typically determine if MiMedx is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MiMedx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.